| Affiliation: | 1. University of Alabama at Birmingham, Alabama;2. Heinrich‐Heine University, Düsseldorf, Germany;3. (Retired) Children's Hospital of Eastern Ontario, Ottawa, Canada;4. Tohoku University School of Medicine, Sendai, Japan;5. Children's Tumor Foundation, New York, New York;6. Manchester Centre for Genomic Medicine, UK;7. Manchester Academic Health Science Center, Manchester, UK;8. Parent Project Muscular Dystrophy, Hackensack, New Jersey;9. Erasmus University, Netherlands;10. Icahn School of Medicine at Mount Sinai, New York;11. A.I. duPont Hospital for Children, Wilmington, Delaware;12. Manchester Centre for Genomic Medicine, Manchester, UK;13. Harvard Medical School and Beth Israel Deaconess Medical Cancer Center, Boston, Massachusetts;14. Catalan Institute of Oncology (ICO‐IDIBELL), Barcelona, Spain;15. Duke University School of Medicine, Durham, North Carolina;16. UC California, Davis, California;17. Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts;18. Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada;19. Massachusetts General Hospital, Boston, Massachusetts;20. University of California, Davis MIND Institute, Sacramento, California;21. Boston Children's Hospital, Massachusetts;22. Harvard Medical School, Massachusetts;23. University of California, Los Angeles, California;24. National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, Maryland;25. Plexxikon, Inc., Berkeley, California;26. RASopathies Network USA |
